Severe hyponatremia caused by hyperglycaemia due to interferon alpha therapy in advanced renal cell carcinoma.
Soetekouw
Patricia M M B
PM
Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. p.soetekouw@sint.azm.nl
Koopman
M
M
Burger
David
D
Tjan-Heijnen
Vivianne C G
VC
De Mulder
P H M
PH
D002292:Carcinoma, Renal Cell / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced*; D007010:Hyponatremia / Q000097:blood / Q000209:etiology*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins